We found a unique association between a SDHB pathogenic variant and a VUS of MLH1 in a patient with PHEO diagnosed at 36 years old; he did not develop metastatic disease at 7 years of follow‐up. This evidence concerns the gene MLH1 and metastatic neoplasm.